![](data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxMDAwIiBoZWlnaHQ9IjQ4MCIgdmlld0JveD0iMCAwIDEwMDAgNDgwIj48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzdHlsZT0iZmlsbDojY2ZkNGRiO2ZpbGwtb3BhY2l0eTogMC4xOyIvPjwvc3ZnPg==)
Most people with hemophilia have a positive attitude toward gene therapy, and are willing or “very willing” to receive this treatment, according to a small interview study assessing patient perceptions… (Click source article below to continue reading) Source: Most Hemophilia Patients Show Positive Attitude for Gene Therapy…
![](data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxNDAwIiBoZWlnaHQ9IjgzNCIgdmlld0JveD0iMCAwIDE0MDAgODM0Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzdHlsZT0iZmlsbDojY2ZkNGRiO2ZpbGwtb3BhY2l0eTogMC4xOyIvPjwvc3ZnPg==)
Source: Hemophilia A Patients Using Hemlibra Show Gains in Joint Health, Trial Data Show
![](data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxMDAwIiBoZWlnaHQ9IjcyMiIgdmlld0JveD0iMCAwIDEwMDAgNzIyIj48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzdHlsZT0iZmlsbDojY2ZkNGRiO2ZpbGwtb3BhY2l0eTogMC4xOyIvPjwvc3ZnPg==)
In our bleeding disorder practice, teaching self-infusion is a key component of most care plans. Our home infusion nurses, specializing in bleeding disorders are the key to independence for many many patients. An unexpected injury was an opportunity for columnist Jared Formalejo to finally learn how to self-infuse. Although difficult, the experience was rewarding. Source: […]
![](data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIxMDAwIiBoZWlnaHQ9IjY2NyIgdmlld0JveD0iMCAwIDEwMDAgNjY3Ij48cmVjdCB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzdHlsZT0iZmlsbDojY2ZkNGRiO2ZpbGwtb3BhY2l0eTogMC4xOyIvPjwvc3ZnPg==)
Preventive treatment with Hemlibra reduces bleeding rates in children younger than 12 with hemophilia type A regardless of inhibitor status, data show. Source: Data: Hemlibra OK in Kids with Hemophilia A Regardless of Inhibitor Status